Why do so many cancers resist treatment — even when patients receive the strongest chemotherapy available?

In this episode, Dr. Dino Prato, founder of Envita Medical Centers, explains the “Great Wall of Cancer”: a fibrous stromal barrier that surrounds many tumors. This wall blocks chemotherapy, immunotherapy, and even the body’s own immune system from reaching the cancer.

Dr. Prato discusses how this barrier forms, why it accelerates metastasis in cancers like pancreatic, breast, stomach, colorectal, and head and neck cancers, and how Envita uses advanced testing to identify and measure it.

🎯 What You’ll Learn in This Episode:

• Why IV chemotherapy often delivers less than 5% of the drug to the tumor
• How stromal barriers weaken immune cells and push cancer to spread
• The role of spatial biology, molecular profiling, and precision testing in mapping tumor defenses
• How interventional radiology delivers medicine directly inside tumors using tiny catheters
• Why CIPI (Chemo-Immuno-Precision Injection) improves outcomes and activates the immune system
• A real case study where stage IV neuroendocrine carcinoma was successfully treated with this method

📊 In published outcomes, patients receiving these precision approaches saw significant improvements in survival and quality of life compared to standard treatments.*
*(See Outcomes Disclaimer Below)

“Cancer may build a wall — but precision oncology helps break it down.”

Disclaimer
This podcast is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always consult your licensed healthcare provider before making any medical decisions. Individual results will vary, and Envita Medical Centers does not guarantee outcomes. Some treatments discussed may not be FDA-approved or available in all locations. Testimonials are shared with patient consent and may not reflect typical results. Do not delay or disregard professional medical care based on the podcast's content. Certain treatments may be available only at Envita’s international clinic in Hermosillo, Mexico. No specific outcomes are promised or implied.
________________________________________
Outcomes Disclaimer
The results referenced from Envita's Precision Cancer Care: 35-Fold Improvement in Response Rates are from a retrospective analysis of 199 late-stage cancer patients treated at Envita Medical Centers between 2021 and 2023, as published in the Journal of Cancer Therapy. These outcomes are not guaranteed and will vary based on individual factors such as cancer type, stage, genetics, immunity and prior treatments. Any comparisons to standard care or clinical trials are based on published data and internal analysis, not head-to-head studies. Individual results will vary.

You can read the full peer-reviewed study at:

https://www.scirp.org/journal/paperinformation?paperid=132493

Are we really curing cancer… or just managing it for a little longer?

In this compelling episode, Dr. Dino Prato, founder of Envita Medical Centers, reveals the uncomfortable truth behind many FDA-approved cancer drugs: they often provide only 2–3 months of life extension, with little to no improvement in quality of life.

🎯 What You’ll Learn:

• Why many cancer drugs are approved without long-term survival data
• The problem with “Fast Track” approvals and tumor shrinkage as a success metric
• How precision oncology uses multi-omics (RNA, DNA, immune, spatial biology) to guide care
• The difference between managing tumors and striving for durable remission
• How adaptive targeting, microdosing, and interventional delivery aim to reduce resistance and increase response
• What real-time biomarkers (ctDNA, immune signals, tumor microenvironment) tell us about treatment progress

📊 According to Envita’s data, patients mapped with this precision model show improved outcomes, better quality of life, and fewer side effects compared to conventional care — all without relying on “trial and error.”*
*(See Outcomes Disclaimer Below)

“Cancer treatment should aim for long-term remission — not just short-term control.”

Disclaimer
This podcast is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always consult your licensed healthcare provider before making any medical decisions. Individual results will vary, and Envita Medical Centers does not guarantee outcomes. Some treatments discussed may not be FDA-approved or available in all locations. Testimonials are shared with patient consent and may not reflect typical results. Do not delay or disregard professional medical care based on the podcast's content. Certain treatments may be available only at Envita’s international clinic in Hermosillo, Mexico. No specific outcomes are promised or implied.
________________________________________
Outcomes Disclaimer
The results referenced from Envita's Precision Cancer Care: 35-Fold Improvement in Response Rates are from a retrospective analysis of 199 late-stage cancer patients treated at Envita Medical Centers between 2021 and 2023, as published in the Journal of Cancer Therapy. These outcomes are not guaranteed and will vary based on individual factors such as cancer type, stage, genetics, immunity and prior treatments. Any comparisons to standard care or clinical trials are based on published data and internal analysis, not head-to-head studies. Individual results will vary.

You can read the full peer-reviewed study at:

https://www.scirp.org/journal/paperinformation?paperid=132493

Do alternative cancer treatments really work? The answer: sometimes — but only if they’re targeted to your unique cancer.

In this episode, Dr. Dino Prato, founder of Envita Medical Centers, explains why integrative tools like high-dose vitamin C, ozone therapy, methylene blue, ivermectin, and mebendazole can be powerful — but not when they’re given the same way to every patient.

Dr. Prato breaks down how cancer’s biology — from oxygen levels to immune signaling — determines whether these therapies succeed or fail. He shows why adding oxygen support, blocking drug-resistance pumps, or stopping tumor blood supply can enhance chemo only when matched to the right molecular targets.

🎯 What You’ll Learn in This Episode:

• Why “one-size-fits-all” integrative care often fails patients
• How oxygen plays a critical role in tumor growth and resistance
• The science behind high-dose vitamin C, ozone therapy, methylene blue, ivermectin, and mebendazole
• Why combinations of conventional + integrative therapies can be more effective
• The importance of transcriptomics, immune profiling, and tumor microenvironment testing
• Why data-driven targeting beats dogma in both conventional and alternative medicine
• In our experience, patients see the best outcomes when integrative therapies are customized using precision oncology testing — not applied as blanket treatments.

“Alternative treatments can help — but only when guided by data, not guesswork.”

Disclaimer
This podcast is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always consult your licensed healthcare provider before making any medical decisions. Individual results will vary, and Envita Medical Centers does not guarantee outcomes. Some treatments discussed may not be FDA-approved or available in all locations. Testimonials are shared with patient consent and may not reflect typical results. Do not delay or disregard professional medical care based on the podcast's content. Certain treatments may be available only at Envita’s international clinic in Hermosillo, Mexico. No specific outcomes are promised or implied.
________________________________________
Outcomes Disclaimer
The results referenced from Envita's Precision Cancer Care: 35-Fold Improvement in Response Rates are from a retrospective analysis of 199 late-stage cancer patients treated at Envita Medical Centers between 2021 and 2023, as published in the Journal of Cancer Therapy. These outcomes are not guaranteed and will vary based on individual factors such as cancer type, stage, genetics, immunity and prior treatments. Any comparisons to standard care or clinical trials are based on published data and internal analysis, not head-to-head studies. Individual results will vary.

You can read the full peer-reviewed study at: https://www.scirp.org/journal/paperinformation?paperid=132493

Why does standard cancer care so often fail? Because it’s based on averages, not on you.

In this episode, Dr. Dino Prato, founder of Envita Medical Centers, explains why the old model of “one-size-fits-all” oncology is broken — and how N of one precision oncology removes the guesswork. Instead of relying only on clinical trial averages, precision oncology analyzes thousands of data points unique to each tumor, including RNA transcriptomics, DNA genomics, immune profiling, spatial biology, and metabolomics.

Dr. Prato reveals how this approach delivers dramatically better outcomes for late-stage patients in Envita’s published clinical data — showing 34x better treatment responses, 43x better quality of life, and 95x fewer side effects compared to standard protocols.*
*(See Outcomes Disclaimer Below)

🎯 What You’ll Learn in This Episode:

• Why clinical trial “averages” fail patients with advanced cancers
• How iPredict and WINTHER trials proved genetic + transcriptomic matching improves survival
• The power of multi-omics: RNA, DNA, immune profiling, metabolomics, spatial biology
• How infections and toxins drive cancer growth and resistance
• Why guided, adaptive care outperforms trial-and-error regimens
• The essential questions every patient should ask their oncologist

In our experience, precision oncology is transforming care — from blind protocols to targeted treatments designed for each patient’s unique cancer fingerprint.

“Don’t settle for averages. Remove the guesswork and demand precision.”

Disclaimer
This podcast is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always consult your licensed healthcare provider before making any medical decisions. Individual results will vary, and Envita Medical Centers does not guarantee outcomes. Some treatments discussed may not be FDA-approved or available in all locations. Testimonials are shared with patient consent and may not reflect typical results. Do not delay or disregard professional medical care based on the podcast's content. Certain treatments may be available only at Envita’s international clinic in Hermosillo, Mexico. No specific outcomes are promised or implied.
________________________________________
Outcomes Disclaimer
The results referenced from Envita's Precision Cancer Care: 35-Fold Improvement in Response Rates are from a retrospective analysis of 199 late-stage cancer patients treated at Envita Medical Centers between 2021 and 2023, as published in the Journal of Cancer Therapy. These outcomes are not guaranteed and will vary based on individual factors such as cancer type, stage, genetics, immunity and prior treatments. Any comparisons to standard care or clinical trials are based on published data and internal analysis, not head-to-head studies. Individual results will vary.

You can read the full peer-reviewed study at: https://www.scirp.org/journal/paperinformation?paperid=132493

What if the biggest cause of cancer isn’t just sugar, stress, or genetics — but hidden infections and toxins no one is testing for?

In this hard-hitting episode, Dr. Dino Prato, founder of Envita Medical Centers, unpacks the real root causes of cancer — and why so many go undetected by conventional medicine. Backed by 25+ years of treating advanced cases, he explains how infections, chemical toxins, immune dysfunction, mitochondrial failure, and chronic stress create the perfect storm for cancer development and resistance.

🎯 What You’ll Learn:

• Why cancer is often driven by both mitochondrial damage and mutations
• The role of infections like Epstein-Barr, HHV-6, Lyme, and fungal mycotoxins
• How stress, trauma, and emotional toxicity impact immune function
• Why gut health, nutrient density, and mitochondrial repair are critical for healing
• How early screening, detoxification, and targeted nutrition support prevention and recovery
  
  

If you’ve ever wondered what caused your cancer — or how to lower your risk — this episode offers the roadmap.

Disclaimer
This podcast is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always consult your licensed healthcare provider before making any medical decisions. Individual results will vary, and Envita Medical Centers does not guarantee outcomes. Some treatments discussed may not be FDA-approved or available in all locations. Testimonials are shared with patient consent and may not reflect typical results. Do not delay or disregard professional medical care based on the podcast's content. Certain treatments may be available only at Envita’s international clinic in Hermosillo, Mexico. No specific outcomes are promised or implied.
________________________________________
Outcomes Disclaimer
The results referenced from Envita's Precision Cancer Care: 35-Fold Improvement in Response Rates are from a retrospective analysis of 199 late-stage cancer patients treated at Envita Medical Centers between 2021 and 2023, as published in the Journal of Cancer Therapy. These outcomes are not guaranteed and will vary based on individual factors such as cancer type, stage, genetics, immunity and prior treatments. Any comparisons to standard care or clinical trials are based on published data and internal analysis, not head-to-head studies. Individual results will vary.

You can read the full peer-reviewed study at: https://www.scirp.org/journal/paperinformation?paperid=132493

What if your cancer is so hard to treat... because no one’s targeting the real causes?

In this deep-dive episode, Dr. Dino Prato, founder of Envita Medical Centers, explains the true nature of treatment resistance in cancer — and why standard care often falls short. From mutations and mitochondrial dysfunction to hidden infections and immune evasion, most patients are only getting a fraction of the story.

🎯 What You’ll Learn:

• Why cancer is biphasic: mitochondrial and mutational drivers
  
  
• How toxins, infections (like EBV, Lyme, fungi), and hypoxia feed cancer
  
  
• Why standard chemo may actually cause resistance and immune collapse
  
  
• How DAMPs, NK cells, and targeted chemo can flip the immune system back on
  
  
• The role of precision testing: RNA, spatial biology, tumor microenvironment
  
  
• How interventional radiology (TACE) delivers chemo directly to tumors with less damage
  
  

📊 In our clinical experience, patients receiving precision-based, low-dose, and interventional therapies have shown reduced side effects, improved outcomes, and better quality of life.

Disclaimer
This podcast is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always consult your licensed healthcare provider before making any medical decisions. Individual results will vary, and Envita Medical Centers does not guarantee outcomes. Some treatments discussed may not be FDA-approved or available in all locations. Testimonials are shared with patient consent and may not reflect typical results. Do not delay or disregard professional medical care based on the podcast's content. Certain treatments may be available only at Envita’s international clinic in Hermosillo, Mexico. No specific outcomes are promised or implied.
________________________________________
Outcomes Disclaimer
The results referenced from Envita's Precision Cancer Care: 35-Fold Improvement in Response Rates are from a retrospective analysis of 199 late-stage cancer patients treated at Envita Medical Centers between 2021 and 2023, as published in the Journal of Cancer Therapy. These outcomes are not guaranteed and will vary based on individual factors such as cancer type, stage, genetics, immunity and prior treatments. Any comparisons to standard care or clinical trials are based on published data and internal analysis, not head-to-head studies. Individual results will vary.

You can read the full peer-reviewed study at: https://www.scirp.org/journal/paperinformation?paperid=132493

What if the biggest risk of chemotherapy isn’t the cancer… but what it does to your immune system?

In this eye-opening episode, Dr. Dino Prato, founder of Envita Medical Centers, explains why conventional chemotherapy — especially when given at maximum tolerated doses — may increase the risk of long-term immune suppression, inflammation, and even resistance.

🧬 Discover how genetically targeted, low-dose chemotherapy (also known as metronomic or fractionated chemotherapy) is designed to support immune function while precisely attacking tumors.

🎯 What You’ll Learn:

• Why standard chemo protocols often don’t match the patient’s unique molecular profile
• The role of DAMPs (Damage-Associated Molecular Patterns) in immune signaling
• How combining genomics, transcriptomics, immune profiling, and targeted delivery methods may reduce toxicity and improve outcomes
• When interventional delivery (chemo directly to the tumor) might offer better precision
• Why timing, dosage, and recovery planning are critical to treatment success
  
  

At Envita, we believe better data leads to smarter, more immune-friendly cancer care — especially for patients who’ve already failed conventional options.

Disclaimer
This podcast is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always consult your licensed healthcare provider before making any medical decisions. Individual results will vary, and Envita Medical Centers does not guarantee outcomes. Some treatments discussed may not be FDA-approved or available in all locations. Testimonials are shared with patient consent and may not reflect typical results. Do not delay or disregard professional medical care based on the podcast's content. Certain treatments may be available only at Envita’s international clinic in Hermosillo, Mexico. No specific outcomes are promised or implied.
________________________________________
Outcomes Disclaimer
The results referenced from Envita's Precision Cancer Care: 35-Fold Improvement in Response Rates are from a retrospective analysis of 199 late-stage cancer patients treated at Envita Medical Centers between 2021 and 2023, as published in the Journal of Cancer Therapy. These outcomes are not guaranteed and will vary based on individual factors such as cancer type, stage, genetics, immunity and prior treatments. Any comparisons to standard care or clinical trials are based on published data and internal analysis, not head-to-head studies. Individual results will vary.

You can read the full peer-reviewed study at: https://www.scirp.org/journal/paperinformation?paperid=132493

Providing support and acting as a patient advocacy is an incredible act of love for a cancer patient or anyone facing chronic pain. Navigating medical decision making can be overwhelming, but remember you're not alone. Our team provides patient care and advocacy to help guide you.

Supporting someone with cancer? You're not alone. And your role could change everything.

In this heartfelt episode, Dr. Dino Prato, founder of Envita Medical Centers, shares a message for spouses, children, friends, and caregivers acting as advocates for someone facing cancer. If you're overwhelmed by medical choices, insurance limits, or unclear next steps — this is for you.

👥 What You’ll Learn:

• Why advocates are often the ones who ask the right questions
• The dangers of one-size-fits-all cancer care
• How precision targeting (DNA, RNA, immune profiling) can uncover personalized treatment options
• What to consider when navigating costs, insurance, and non-covered options
• The importance of testing before treatment — and slowing down rushed decisions
  
  

🔬 Precision care isn’t just about using more tools — it’s about using the right ones for each patient. That’s how Envita has helped thousands of patients who’ve failed conventional care find renewed options, and in many cases, improved quality of life.

🎯 “The best care is the one that’s best targeted for the individual.”

Disclaimer
This podcast is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always consult your licensed healthcare provider before making any medical decisions. Individual results will vary, and Envita Medical Centers does not guarantee outcomes. Some treatments discussed may not be FDA-approved or available in all locations. Testimonials are shared with patient consent and may not reflect typical results. Do not delay or disregard professional medical care based on the podcast's content. Certain treatments may be available only at Envita’s international clinic in Hermosillo, Mexico. No specific outcomes are promised or implied.
________________________________________
Outcomes Disclaimer
The results referenced from Envita's Precision Cancer Care: 35-Fold Improvement in Response Rates are from a retrospective analysis of 199 late-stage cancer patients treated at Envita Medical Centers between 2021 and 2023, as published in the Journal of Cancer Therapy. These outcomes are not guaranteed and will vary based on individual factors such as cancer type, stage, genetics, immunity and prior treatments. Any comparisons to standard care or clinical trials are based on published data and internal analysis, not head-to-head studies. Individual results will vary.

You can read the full peer-reviewed study at: https://www.scirp.org/journal/paperinformation?paperid=132493